Sinil Pharmaceutical Co., Ltd. (012790.KQ) Stock

012790.KQ logo

Sinil Pharmaceutical Co., Ltd.

012790.KQSouth Korea
Healthcare

Company profile

Sinil Pharmaceutical reported revenue of 80.56 billion KRW for fiscal year 2025, down 9.9% from fiscal year 2024, and net income of 7.53 billion KRW. That is a net profit margin of 9.3% for fiscal year 2025. Our analysis of its filings shows revenue shrinking from 89.14 billion KRW in fiscal year 2023 to 80.56 billion KRW in fiscal year 2025, 4.9% a year on average.

Figures from company filings; latest fiscal year ended December 31, 2025.

About Sinil Pharmaceutical Co., Ltd.

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Largest shareholders

  • Jae-Hyun Hong20.08 %20.08%
  • Sinil Pharmaceutical Co., Ltd.3.56%
  • Chung-hee Hong2.019 %2.02%
  • Sung-So Hong1.999 %2.00%
  • Seok-yoon Hong1.927 %1.93%

Share of the company, as of May 19, 2026

Leadership

  • Mi-Keun Jung — Chief Executive Officer and President, 71

How much revenue does Sinil Pharmaceutical make?

Sinil Pharmaceutical reported 80.56 billion KRW in revenue for fiscal year 2025, down 9.9% from 89.44 billion KRW in fiscal year 2024.

What companies are similar to Sinil Pharmaceutical?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Dong Sung Bio Pharm.Co.,Ltd. (002210.KS), Withus Pharmaceutical Co.,LTD. (330350.KQ), Korea Pharma Co., Ltd. (032300.KQ), Daehan Nupharm Co.,Ltd. (054670.KQ).

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
HeadquartersChungju-si, South Korea
ExchangeKOSDAQ
TimezoneAsia/Seoul (KST)

Contact & Links

Address
28, Boksanggol-gil, Chungju-si
Phone
82 4 3722 3300
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Sinil Pharmaceutical Co., Ltd. (012790.KQ)”, data as of May 19, 2026, https://dataporium.tech/stocks/012790.KQ

LinkedInLinkedInXXYouTubeYouTube